Literature DB >> 24740228

Circulating cell-free DNA in cancer.

Pamela Pinzani1, Francesca Salvianti, Claudio Orlando, Mario Pazzagli.   

Abstract

This papers deals with the preanalytical and analytical phase of cell-free DNA analysis, highlighting some criticism on sample collection and extraction. We describe a method to accurately quantify total cfDNA in plasma and our particular approach to the measurement of tumor deriving cfDNA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740228     DOI: 10.1007/978-1-4939-0733-5_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Circulating tumor DNA: a resuscitative gold mine?

Authors:  Zhaohui Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-10

Review 2.  Pathologists and liquid biopsies: to be or not to be?

Authors:  Paul Hofman; Helmut H Popper
Journal:  Virchows Arch       Date:  2016-08-23       Impact factor: 4.064

Review 3.  Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Authors:  Marius Ilie; Véronique Hofman; Elodie Long; Olivier Bordone; Eric Selva; Kevin Washetine; Charles Hugo Marquette; Paul Hofman
Journal:  Ann Transl Med       Date:  2014-11

Review 4.  Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis.

Authors:  Jing Yang; Li Cheng; Jing Zhang; Linyan Chen; Denian Wang; Xinli Guo; Xuelei Ma
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Clinical significance of plasma free DNA in patients with non-small cell lung cancer.

Authors:  Lanxiang Ma; Jie Du; Yongjie Sui; Shuili Wang
Journal:  J Int Med Res       Date:  2019-09-23       Impact factor: 1.671

Review 6.  Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes.

Authors:  Zuzana Pös; Ondrej Pös; Jakub Styk; Angelika Mocova; Lucia Strieskova; Jaroslav Budis; Ludevit Kadasi; Jan Radvanszky; Tomas Szemes
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.